MedTrace Logo

Small Particle Steroids in Refractory Asthma

NCT01171365 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2014-01-31

No results posted yet for this study

Summary

The purpose of this study is to determine whether an inhaled steroid with a small particle size can be an additional treatment option in patients with refractory eosinophilic asthma.

Conditions

Interventions

DRUG

Ciclesonide

Inhaled ciclesonide 320mcg twice daily

DRUG

Placebo

Matched placebo inhaler two inhalations twice daily

Sponsors & Collaborators

  • Nottingham University Hospitals NHS Trust

    collaborator OTHER

  • University Hospitals, Leicester

    collaborator OTHER

  • University of Nottingham

    lead OTHER

Principal Investigators

  • Tim Harrison · University of Nottingham

  • Ian Pavord · University Hospitals, Leicester

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-01-31
Primary Completion
2013-10-31
Completion
2013-12-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01171365 on ClinicalTrials.gov